MedPath

Management of Patients With Suspected of Sleep Apnea-hypopnea Syndrome From Primary Care

Not Applicable
Completed
Conditions
Sleep Apnea Syndrome
Interventions
Other: Primary Care-based management
Other: Standard management
Registration Number
NCT02234765
Lead Sponsor
Sociedad Española de Neumología y Cirugía Torácica
Brief Summary

Obstructive sleep apnea syndrome (OSA) is characterized by the manifestation of excessive sleepiness secondary to repeated obstruction of the upper airway during sleep and cognitive-behavioral, respiratory, cardiac, metabolic or inflammatory disorders. Epidemiological studies in our country have shown that OSA is a highly prevalent disease in the general population, affecting 2-4% of the adult population. The most important clinical manifestations of OSAS is a deterioration in the quality of life and an increase in cardiovascular disease. OSA is also associated with traffic accidents. Therefore, and considering the medical complications of OSA, as well as the sociolaboral impact and its negative impact on quality of life and survival; is stated that this disease is a public health problem that requires the physician to identify patients eligible to treatment. Moreover, it has been shown that undiagnosed patients, duplicate the consumption of health resources, comparing when the diagnosis and treatment has been established. Finally, we have a highly effective treatment using positive pressure in the upper airway (CPAP) that has been shown to be effective and cost-effective. The current situation in which all patients diagnosed with OSA and receiving different treatments are monitored and controlled by the Sleep Units (SU) is an oversized medicine specialist at the expense of primary care (PC). Our working hypothesis is: "By the coordination of actions at various levels including interactive training equipment AP, use the bilateral (SU-AP) of electronic medical records and the use of new technologies can be achieved in AP satisfactory management of the diagnostic and therapeutic process of patients with suspected OSA. Patients assisted in both areas have a level of clinical response, satisfaction, compliance and avoidance of complications, similar to that obtained with monitoring by SU. In addition, management by AP will be more cost-effective than in the SU."

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
280
Inclusion Criteria
  • Men and women over 18 years old
  • Suspected OSA patients (chronic snoring, apneas, excessive daytime sleepiness) or resistant hypertension
  • Written informed consent signed
Exclusion Criteria
  • Patients with impaired lung function (sd. overlap, obesity hypoventilation, and restrictive disorders)
  • Severe heart failure
  • Severe chronic pathology associated
  • Psychiatric disorder
  • Periodic leg movements
  • Pregnancy
  • Other dyssomnias or parasomnias
  • Patients already treated with CPAP

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Primary CarePrimary Care-based managementPatients diagnosed and followed up in the Primary Care.
Sleep UnitStandard managementPatients diagnosed and followed up in the Sleep Unit.
Primary Outcome Measures
NameTimeMethod
Change from baseline in daytime sleepiness (ESS score) at 6 monthsbaseline and 6 months

Epworth Sleepiness Scale (ESS)

Cost-effectiveness at 6 months6 months

QUALYS

Secondary Outcome Measures
NameTimeMethod
Change from baseline in body mass indexBaseline and 6 months
Adverse events at 6 months6 months

Adverse events / secondary effects related to CPAP compliance.

Change from baseline in blood pressureBaseline and 6 months

Office blood pressure

Lost of follow up / Abandons at 6 months6 months
Change from baseline in quality of lifebaseline and 6 months

EuroQol (EQ5D)

CPAP compliance at 6 months6 months

Objective data to be downloaded from the CPAP device

Satisfaction at 6 months6 months

Visual analog scale

Trial Locations

Locations (1)

Hospital Arnau de Vilanova-Santa María

🇪🇸

Lleida, Spain

© Copyright 2025. All Rights Reserved by MedPath